OM
OCUL icon

Opaleye Management’s Ocular Therapeutix OCUL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$14.8M Hold
1,595,000
3% 9
2025
Q1
$11.7M Sell
1,595,000
-2,747,500
-63% -$20.1M 2.6% 10
2024
Q4
$37.1M Sell
4,342,500
-682,500
-14% -$5.83M 6.49% 5
2024
Q3
$43.7M Sell
5,025,000
-282,500
-5% -$2.46M 7.29% 3
2024
Q2
$36.3M Sell
5,307,500
-1,345,638
-20% -$9.2M 8.29% 3
2024
Q1
$60.5M Buy
6,653,138
+583,138
+10% +$5.31M 13.19% 1
2023
Q4
$27.1M Sell
6,070,000
-398,000
-6% -$1.78M 7.2% 5
2023
Q3
$20.3M Buy
6,468,000
+688,000
+12% +$2.16M 6.61% 3
2023
Q2
$29.8M Sell
5,780,000
-325,900
-5% -$1.68M 7.13% 3
2023
Q1
$32.2M Buy
6,105,900
+30,900
+0.5% +$163K 9.64% 2
2022
Q4
$17.1M Sell
6,075,000
-390,000
-6% -$1.1M 5.94% 4
2022
Q3
$26.8M Buy
6,465,000
+490,200
+8% +$2.03M 11.08% 2
2022
Q2
$24M Hold
5,974,800
10.83% 2
2022
Q1
$29.6M Hold
5,974,800
9.18% 1
2021
Q4
$41.6M Sell
5,974,800
-505,200
-8% -$3.52M 8.83% 2
2021
Q3
$64.8M Hold
6,480,000
12.1% 1
2021
Q2
$91.9M Hold
6,480,000
15.26% 1
2021
Q1
$106M Sell
6,480,000
-30,000
-0.5% -$492K 15.62% 1
2020
Q4
$135M Buy
6,510,000
+525,800
+9% +$10.9M 17.6% 1
2020
Q3
$45.5M Hold
5,984,200
8.91% 1
2020
Q2
$49.8M Buy
5,984,200
+861,700
+17% +$7.18M 10.07% 2
2020
Q1
$25.4M Buy
5,122,500
+15,000
+0.3% +$74.2K 6.72% 3
2019
Q4
$20.2M Buy
5,107,500
+2,332,500
+84% +$9.21M 3.96% 7
2019
Q3
$8.44M Sell
2,775,000
-175,000
-6% -$532K 3.05% 9
2019
Q2
$13M Buy
2,950,000
+1,050,000
+55% +$4.62M 3.96% 7
2019
Q1
$7.54M Buy
+1,900,000
New +$7.54M 2.09% 20
2018
Q4
Sell
-800,000
Closed -$5.5M 52
2018
Q3
$5.5M Sell
800,000
-311,000
-28% -$2.14M 1.4% 25
2018
Q2
$7.5M Hold
1,111,000
1.94% 16
2018
Q1
$7.23M Buy
+1,111,000
New +$7.23M 2.07% 15
2017
Q2
Sell
-550,000
Closed -$5.1M 47
2017
Q1
$5.1M Buy
550,000
+456,400
+488% +$4.24M 2.54% 15
2016
Q4
$783K Buy
+93,600
New +$783K 0.46% 37
2016
Q3
Sell
-260,000
Closed -$1.29M 49
2016
Q2
$1.29M Buy
+260,000
New +$1.29M 0.86% 40